MAR 03, 2020 9:00 AM PST

The Importance of CPO Carriers Within the Healthcare System

Sponsored by: BD
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Clinical Professor of Pathology and Laboratory Medicine University of Louisville School of Medicine
    Biography
      Dr Thomson received his Ph.D. from the University of Tasmania, Australia, and directed the Microbiology Laboratory at the Repatriation General Hospital, Hobart, Tasmania until he moved to the United States in 1988. In the United States his professional positions include:
      • Professor of Clinical Microbiology & Immunology and Director of Antibiotic Research at Creighton University, Omaha, Nebraska
      • Senior Scientist at Covance, Indianapolis, Indiana
      • Clinical Professor of Pathology and Laboratory Medicine at University of Louisville, Louisville, Kentucky

      He was an editor of Clinical Microbiology Reviews for 10 years, a member of several editorial boards, Chair of the Antimicrobial Chemotherapy Division of the American Society for Microbiology, and is a Fellow of the Infectious Diseases Society of America; the American Academy of Microbiology; and the Australian Society for Microbiology, and is a member of the Australian Cricketers Association.
      He is a grant reviewer for several national and international government agencies and has 113 first-author and co-author publications and over 420 presentations at educational forums throughout the world. His research interests are antibiotic resistance, clinical relevance of antibiotic susceptibility tests, and β-lactam antibiotics.

    Abstract
    DATE:  March 3, 2020
    TIME:  9:00am PT, 12:00pm ET
     
    Despite the advances of new drugs and the lowering of carbapenem breakpoints to enhance detection of CRE, there should be no complacency about the future of antibacterial therapy. Without effective counter-measures, the prevalence of carriage of carbapenemase-producing organisms (CPOs) and of CPO infections with bad outcomes can be expected to increase. There are three potentially effective counter-measures - the utilization of new anti-CPO antibiotics, antibiotic stewardship, and infection control. Unfortunately, resistance is emerging to the new antibiotics and companies developing them are going bankrupt. There is a lack of convincing evidence about which antibiotic stewardship strategies are effective for countering antibiotic resistance. Therefore, infection control remains the most effective counter-measure. The most crucial components of infection control are effective hand hygiene and rapid CPO detection leading to appropriate interventions that may include surveillance, contact precautions, and disinfection. This presentation focuses on the role of the microbiology laboratory to prevent the spread of carbapenemase-producing organisms or CPOs, with particular emphasis on detection of CPO carriers. Issues addressed will include when, how, and why the laboratory should do tests to detect CPO carriers.
     
    At the completion of the session, attendees will be able to understand:
    • The clinical importance of CPOs
    • The need for laboratory detection
    • The role of the laboratory in detecting carriage of CPOs
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources